Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

     IN WITNESS WHEREOF, the parties have executed this Investors’ Rights Agreement as of the date first above written.
         
  COMPANY:


Orexigen Therapeutics, Inc.,

a Delaware corporation
 
 
  By:      
    John F. Crowley,   
    President and Chief Executive Officer   
 
[Signature Page to Investors’ Rights Agreement]